CHO Pharma Inc (6586)

TPEX

Currency in TWD

113.00

-0.50(-0.44%)

Closed·14/08

Fair Value

Unlock Value

Day's Range

111.00

115.00

52 wk Range

22.75

148.50

6586 Income Statement

Featured here, the Income Statement (earnings report) for CHO Pharma Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

3.57

0.06

3.58

1.43

Total Revenues Growth

aa.aa

+2,486.96%

-98.32%

-60.03%

Cost Of Revenues

aa.aa

0.21

1.87

0.37

Gross Profit

aa.aa

3.36

0.06

1.71

1.07

Gross Profit Growth

aa.aa

+4,913.43%

-98.24%

-37.66%

Gross Profit Margin %

aa.aa

94.09%

98.33%

47.77%

74.49%

Other Operating Expenses, Total

aa.aa

213.85

350.96

269

251

326.91

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-30.93%	+64.11%	-23.35%	-6.69%	+30.24%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	193.51	326.1	239.39	219.08	286.85
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	20.35	24.86	29.61	31.93	40.06
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-210.49

-350.9

-269

-249.29

-325.84

Operating Income Growth

aa.aa

+32%

-66.71%

+23.34%

+7.33%

-30.71%

EBIT Margin %

aa.aa

-5,896.11%

-584,833.33%

-6,963.49%

-22,770.16%

Net Interest Expenses

aa.aa

4.89

6.75

16.16

35.86

Net Interest Expenses Growth

aa.aa

-33.4%

+38.24%

+139.32%

+128.94%

-3.08%

Interest Expense, Total

aa.aa

-0.58

-0.3

-0.08

-0.68

-0.41

Interest And Investment Income

aa.aa

5.46

7.05

16.24

37.68

36.26

Other Non Operating Expenses, Total

aa.aa

5.68

5.75

-0.53

0.07

-0.02

EBT, Excl. Unusual Items

aa.aa

-199.93

-338.39

-253.36

-212.23

-290.01

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-6

-52.73

EBT, Incl. Unusual Items

aa.aa

-205.93

-338.39

-306.09

-212.23

-290.01

EBT, Incl. Unusual Items Growth

aa.aa

+30.63%

-64.33%

+9.55%

+30.66%

-36.65%

EBT, Incl. Unusual Items Margin

aa.aa

-5,768.21%

-563,988.33%

-5,928.1%

-20,265.97%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-205.93

-338.39

-306.09

-212.23

-290.01

Minority Interest

aa.aa

Net Income

aa.aa

-205.93

-338.39

-306.09

-212.23

-290.01

Net Income Growth

aa.aa

+30.63%

-64.33%

+9.55%

+30.66%

-36.65%

Net Income Margin %

aa.aa

-5,768.21%

-563,988.33%

-5,928.1%

-20,265.97%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-205.93

-338.39

-306.09

-212.23

-290.01

Basic EPS - Continuing Operations

aa.aa

-1.12

-1.84

-1.6

-0.99

-1.36

Basic EPS - Continuing Operations Growth

aa.aa

+30.71%

-64.26%

+13.03%

+38.02%

-36.65%

Diluted EPS - Continuing Operations

aa.aa

-1.12

-1.84

-1.6

-0.99

-1.36

Diluted EPS - Continuing Operations Growth

aa.aa

+30.86%

-64.29%

+13.04%

+38.02%

-37.14%

Basic Weighted Average Shares Outstanding

aa.aa

183.89

183.96

191.32

214.01

Diluted Weighted Average Shares Outstanding

aa.aa

183.89

183.96

191.32

214.01

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-184.88

-324.67

-250.3

-237.71

-313.46

EBITDA Growth

aa.aa

+34.44%

-75.61%

+22.91%

+5.03%

-31.87%

EBITDA Margin %

aa.aa

-5,178.77%

-541,113.33%

-6,639.89%

-21,905.17%

EBIT

aa.aa

-210.49

-350.9

-269

-249.29

-325.84

* In Millions of TWD (except for per share items)

FAQ

What was CHO Pharma’s revenue at year end?

At the end of the last reported fiscal year, CHO Pharma (6586) recorded total revenue of 1.43 million TWD.

How much revenue did CHO Pharma report in the most recent quarter?

In its most recent quarterly earnings report, CHO Pharma posted revenue of 0.72 million TWD.

What was CHO Pharma’s net income for the year?

For the full year, CHO Pharma reported net income of -290.01 million TWD.

How much net income did CHO Pharma post in the last quarter?

In the most recent quarter, CHO Pharma (6586) posted net income of -171.88 million TWD.

What was CHO Pharma’s gross profit for the year?

Gross profit for the year was reported at 1.07 million TWD.

How much gross profit did CHO Pharma generate last quarter?

CHO Pharma recorded gross profit of 0.56 million TWD in its latest quarterly report.

What was CHO Pharma’s annual operating income?

For the full year, CHO Pharma (6586) reported operating income of -325.84 million TWD.

What was CHO Pharma’s operating income last quarter?

Quarterly operating income was -189.12 million TWD.

What was CHO Pharma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -182.73 million TWD.

What was the quarter-over-quarter change in EBITDA for CHO Pharma?

EBITDA changed by -39.76% million TWD compared to the last quarter.

How did CHO Pharma’s revenue change compared to the previous quarter?

Revenue changed by 0.98% million TWD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for CHO Pharma?

In the latest quarter, gross profit changed by 12.35% million TWD from the previous quarter.

PSEi Composite

6,297.30

+9.05

+0.14%

Nikkei 225

68,713.80

+405.21

+0.59%

Shanghai

3,927.18

+0.21

+0.01%

US 500

7,781.40

-17.8

-0.23%

US Tech 100

30,046.90

-37.6

-0.12%

DAX

26,440.31

+140.57

+0.53%

Dollar Index

99.54

-0.320

-0.32%

Market Movers

Name	Last	Chg. %	Vol.
First Gen	30.70	+9.64%	16.54M
PLDT	1,170.00	-4.49%	417.21K
International Container	982.000	+1.76%	475.86K
Ayala Land	15.600	+4.14%	24.79M
SM Prime	18.280	+0.44%	13.76M
Manila Water	34.800	+4.19%	5.62M
MREIT	13.62	-0.87%	10.69M

Name	Last	Chg. %	Vol.
Swift Foods	0.067	+31.37%	9.40M
Ionics	1.930	+31.29%	32.69M
Xurpas	0.221	+22.10%	6.00M
Cirtek	1.37	+17.09%	23.41M
Jackstones	2.050	+15.82%	9.00K
Bloomberry Resorts	2.380	+14.98%	50.84M
Prime Media	1.070	+11.46%	122.00K

Name	Last	Chg. %	Vol.
Cityland Development	0.550	-12.70%	253.00K
Manila Bulletin	0.176	-11.56%	80.00K
Geograce Resources	0.096	-11.11%	5.14M
Anglo Philippine	1.010	-7.34%	3.90M
Oriental Petrol	0.0130	-7.14%	16.10M
Pilipinas Shell Petroleum	8.400	-6.67%	1.56M
Macay	5.700	-6.56%	2.50K

Trending Stocks

Name	Last	Chg. %	Vol.
Bank of the Philippine Islands	104.00	-2.71%	916.59K
PLDT	1,170.00	-4.49%	417.21K
Cirtek	1.37	+17.09%	23.41M
Semirara Mining	18.44	+0.11%	1.09M
Ayala Land	15.600	+4.14%	24.79M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaaaa A	36.300	+50.31%	54.563
Aaaaaaaaaaaa	7.880	+34.77%	10.620
Aaa Aa	15.600	+29.46%	20.196
Aaaaaa A Aa Aaaaaa	3.540	+25.69%	4.449
Aaaaaaaa	0.2220	+20.14%	0.2667
Aaaaa	53.50	+19.25%	63.80
Aaaaaaaaaaa	511.00	+17.52%	600.53

Name	Last	Upside	Fair Value
A Aaaaaaa A	36.300	+50.31%	54.563
Aaaaaaaaaaaa	7.880	+34.77%	10.620
Aaa Aa	15.600	+29.46%	20.196
Aaaaaa A Aa Aaaaaa	3.540	+25.69%	4.449
Aaaaaaaa	0.2220	+20.14%	0.2667
Aaaaa	53.50	+19.25%	63.80
Aaaaaaaaaaa	511.00	+17.52%	600.53

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

CHO Pharma Inc (6586)

6586 Income Statement

FAQ

What was CHO Pharma’s revenue at year end?

How much revenue did CHO Pharma report in the most recent quarter?

What was CHO Pharma’s net income for the year?

How much net income did CHO Pharma post in the last quarter?

What was CHO Pharma’s gross profit for the year?

How much gross profit did CHO Pharma generate last quarter?

What was CHO Pharma’s annual operating income?

What was CHO Pharma’s operating income last quarter?

What was CHO Pharma’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for CHO Pharma?

How did CHO Pharma’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for CHO Pharma?

Trending Stocks